What is Pulmonary Hypertension?
Pulmonary Hypertension (PAH) begins when tiny arteries in your lungs become narrow or blocked. This causes increased resistance to the flow of blood in the lungs, which in turn raises pressure within the blood vessels or what could be termed "high blood pressure of the lungs." As a result, the right side of the heart, which pumps blood into the lungs, has to pump against a higher resistance to blood flow. This makes it more difficult to pump the blood through the lungs, eventually causing the heart muscle to weaken and sometimes fail completely.
We are currently reviewing new studies for enrollment in the near future.
Patients may still be taking their standard therapies for the treatment of PAH while taking part in this trial.
All patients who qualify to participant in the trial will receive at no cost, study related medical care and study medications.
If you are interested in participating in this study or want more information, contact CardioPulmonary Research Center at 314-439-LUNG (5864).